OBJECTIVE:To examine African-American prostate cancer (PCa) survivors' involvement in treatment decision-making (TDM), and examine the association between TDM and quality of life (QOL), using secondary data.
METHODS:African-American PCa survivors (181) were recruited from the North Carolina Central Cancer Registry. Participants completed a cross-sectional survey that asked about their chosen cancer treatment, TDM factors, and PCa-specific QOL (using the Expanded Prostate Cancer Index Composite - EPIC). Multivariate analysis of covariance was conducted to determine the association between TDM and QOL, controlling for confounders.
RESULTS:Most men reported being active (44.2%) or collaborative (38.1%) in TDM, while 14.4% preferred a passive role. Adjusting for marital status, education and treatment, passive patients reported somewhat better QOL compared to active patients in the following QOL domains: urinary summary (p=0.04), urinary function (p=0.01), and urinary incontinence (p=0.03).
CONCLUSION:Most African-American PCa survivors preferred to be, and were, actively or collaboratively involved in TDM. However, those who preferred a passive role reported better PCa-specific QOL for the urinary domain compared to others.
PRACTICE IMPLICATIONS: It is important to assess patients' TDM preference. Patients' QOL may differ by their TDM role, such that active patients may be more bothered by treatment side effects than other patients.
Written by:
Palmer NR, Tooze JA, Turner AR, Xu J, Avis NE. Are you the author?
Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, USA.
Reference: Patient Educ Couns. 2012 Aug 31. Epub ahead of print.
doi: 10.1016/j.pec.2012.08.007
PubMed Abstract
PMID: 22940374
UroToday.com Prostate Cancer Section
